Dow Up 0.07% Nasdaq Up 0.61%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
415.84 Up 2.84(0.69%) Nov 26, 4:00PM EST
|After Hours : 416.00 Up 0.16 (0.04%) Nov 26, 7:31PM EST
Prev Close:413.00
Open:413.93
Bid:N/A
Ask:423.00 x 100
1y Target Est:404.15
Beta:1.6
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:412.08 - 415.95
52wk Range:257.69 - 419.27
Volume:443,766
Avg Vol (3m):826,185
Market Cap:41.91B
P/E (ttm):142.17
EPS (ttm):2.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.69%41.91B
AMGNUp 1.53%125.30B
NVSUp 0.55%231.13B
RHHBYUp 0.54%254.20B

Key Statistics

Forward P/E (1 yr):35.33
P/S (ttm):15.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :9.97
Quarterly EPS Est (Dec-14) :2.75
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback